To order this 305+ page report, which features 215+ figures and 250+ tables, please visit this link

Key Inclusions

• A detailed assessment of the overall market landscape of the cell and gene therapy bioassay services market, providing information on their year of establishment, company size, location of headquarters, location of bioanalytical facilities, type of offering (in vitro and in vivo), type of bioassay(s) offered (pre-developed assay and customized assay), type of bioanalytical services (immunoassay, potency assay, qualitative PCR, digital droplet PCR, flow cytometry, ELISA, immunochemistry and others) and application area (cell therapy, gene therapy and others).
• A detailed competitiveness analysis of the cell and gene therapy bioassay service providers based in different geographies, by taking into consideration their service strength (in terms of bioassay offering(s) and number of bioanalytical services offered), service applicability (in terms of number of bioassays offered and application area) and supplier strength (in terms of years of experience in this field and company size).
• Tabulated profiles of key players offering a wide range of cell and gene therapy bioassay services across North America, Europe and Asia-Pacific. Each profile includes an overview of the company, financial information (if available), details of its cell and gene therapy bioassay services portfolio, types of offerings, type of bioassay(s) offered, types of bioanalytical services offered, application area, location of bioanalytical facilities, recent developments and an informed future outlook.
• An insightful contemporary market trend analysis, featuring the distribution of cell and gene therapy service providers by type of bioanalytical services offered and application area and an analysis of cell and gene therapy service providers, based on type of bioassay and types of bioanalytical services offered. Further, the chapter also features a schematic world map representation, highlighting the location of bioanalytical facilities of cell and gene therapy bioassay service providers.
• A detailed analysis of the global events attended by the service providers, based on year of event, type of event, type of services involved and application area, and strategic initiatives taken by various cell and gene therapy bioassay service providers.
• A case study of the overall landscape of cell and gene therapy therapeutics market, based on a number of parameters. The market landscape of cell therapies, features distribution of cell therapies across phase of development, therapeutic area and type of developer. Further, the market landscape of cell therapies, features distribution of gene therapies across phase of development of pipeline candidates and key therapeutic areas. The chapter also features information on the developers involved in the domain of cell and gene therapies.
• An in-depth analysis of more than 260 cell therapy developers that are anticipated to partner with cell and gene therapy bioassay service providers and have been shortlisted on the basis of several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development) and availability of other cell therapy capabilities.
• An in-depth analysis of nearly 190 gene therapy developers that are anticipated to partner with cell and gene therapy bioassay service providers and have been shortlisted on the basis of several relevant parameters, such as developer strength (which takes into account a company’s size and its experience in this field), pipeline strength and maturity (based on the number of pipeline drugs and affiliated stage of development) and availability of other gene therapy capabilities.

The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:

• Type of Therapy
  • Cell Therapy
  • Gene Therapy

• Analysis by Scale of Operation
  • Clinical Operation
  • Preclinical Operation
  • Drug Discovery Operation

• Analysis by Therapeutic Area
  • Oncological Disorders
  • Infectious Diseases
  • Autoimmune Disorders
  • Rare / Genetic Disorders
  • Cardiovascular Disorders
  • Metabolic Disorders
  • Blood Disorders
  • Neurological Disorders
  • Ophthalmological Disorders
  • Other Therapeutic Areas

• Analysis by Geographical Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
• MENA

To request sample pages, please visit this link

Key Questions Answered

• Who are the leading services providers offering bioassay services related to cell and gene therapies?
• What is the relative competitiveness of different cell and gene therapy bioassay service providers?
• Which is the commonly offered bioanalytical service (immunoassay, potency assay, qualitative PCR, digital droplet PCR, flow cytometry, ELISA, immunochemistry and others) related to cell and gene therapy?
• What are the key trends within the cell and gene therapy bioassay service providers market?
• What kind of initiatives are being taken by stakeholders engaged in this domain?
• Which players are likely to partner with cell and gene therapy bioassay service providers?
• How is the current and future opportunity likely to be distributed across key market segments?
• What are the anticipated future trends related to teleradiology services market?

You may also be interested in the following titles:

1. Cell and Gene Therapy CROs Market: Industry Trends and Global Forecast (2^nd Edition), 2021-2030
2. Biopharmaceutical CROs Market: Industry Trends and Global Forecast, 2021-2030
3. Pharmaceutical Contract Research Services Market: Industry Trends and Global Forecast, 2021-2030
4. Biospecimen Contract Research Services Market by Therapeutic Area: Industry Trends and Global Forecast, 2021-2030

Contact Us

Ben Johnson

+1 (415) 800 3415

ben.johnson@rootsanalysis.com